NCT02128230 2021-06-22UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionUniversity of ArkansasPhase 2 Terminated20 enrolled 7 charts
NCT01413087 2019-11-01LAPC-BC-819Anchiano Therapeutics Israel Ltd.Phase 2 Terminated12 enrolled 19 charts